Sunscreen Innovation Act

Issues relating to health disparities, health care reform, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including H.R.1666 & S.2800, the Patient Centered Quality Care for Life Act, and, H.R.1339 & S.641, the Palliative Care and Hospice Education and Training Act; S.621 and H.R.2607 & S.1251, the Caroline Pryce Walker Conquer Childhood Cancer Act; H.R.2058 & S.1247 the Childhood Cancer Survivors Quality of Life Act; H.R.2019, the Kids First Research Act; and H.R.460, the Patients' Access to Treatments Act; H.R.5145 & S.2622, the Breast Density & Mammography Reporting Act, H.R.4250 and S.2141, the Sunscreen Innovation Act, and regulations relating to tanning beds. In addition, regulatory issues before the F.D.A relating to laboratory developed tests, colorectal cancer screening tests, electronic medical devices, and issues relating to the 21st Century Cures Initiative of the House Energy & Commerce Committee.

Client expense: $1,340,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office

Blackburn Amendment to H.R. 5016, Amendment to Stop Proposed Rule on Voluntary Recalls Chronic Hazard Advisory Panel (CHAP) Report on Phthalates Cosmetics Regulation Reform CPSC Certificates of Compliance rulemaking ("Part 1110" rule) CPSC Proposed Interpretive Rule: Voluntary Remedial Actions and Guidelines for Voluntary Recall Notices CPSC Proposed Rule: Safety Standard for Recreational Off-Highway Vehicles (ROVs) CPSC Revisions to the Monthly Progress Reporting Form CPSC Section 6(b) Policy Change H.R. 4250, S. 2141, Sunscreen Innovation Act Nomination of Bob Adler for CPSC Commissioner Proposed CPSC Import Surveillance User Fee Third-Party Testing Burden Reduction

Client expense: $3,560,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Army, Dept of (Corps of Engineers), Commerce, Dept of (DOC), Commodity Futures Trading Commission (CFTC), Consumer Product Safety Commission (CPSC), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), Export-Import Bank of the United States (EXIM Bank), Farm Credit Administration, Federal Bureau of Investigation (FBI), Federal Deposit Insurance Corporation (FDIC), Federal Housing Finance Agency (FHFA), Federal Reserve System, Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Internal Revenue Service (IRS), Intl Trade Administration (ITA), Justice, Dept of (DOJ), Labor, Dept of (DOL), Natl Economic Council (NEC), Natl Security Council (NSC), Occupational Safety & Health Administration (OSHA), Office of Management & Budget (OMB), Office of the Comptroller of the Currency (OCC), Patent & Trademark Office (PTO), Pipeline & Hazardous Materials Safety Administration, SENATE, State, Dept of (DOS), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Agency for International Development (USAID), U.S. Customs & Border Protection, U.S. Trade Representative (USTR), White House Office

S. ___ - Legislation that would improve oversight over cosmetic safety (e.g., labeling and safety substantiation); H.R.1385 - Safe Cosmetics and Personal Care Products Act of 2013, all sections; S.2141 and H.R.4250 - Sunscreen Innovation Act, all sections; S.2811 - Children and Firefighters Protection Act of 2014, all sections; H.R.4978 - Bottled Water Quality Information Act, all sections; and S. ___ - Legislation that would require disclosure of information related to bottled water.

Client expense: $178,644 · Firm income: Not reported

Government targets: Council on Environmental Quality (CEQ), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

Dextromethorphan Abuse Reduction; Regulation of OTC drugs, devices and cosmetics; S.644, Preventing Abuse of Cough Treatments Act of 2013; HR 3969, Preventing Abuse of Cough Treatments Act of 2013; S.2141, The Sunscreen Innovation Act; HR 4250, The Sunscreen Innovation Act; HR 4895/S.2902, Microbead-Free Waters Act of 2014; HR 5613, Protecting Our Kids' Medicine Act of 2014

Client expense: $1,242,788 · Firm income: Not reported

Government targets: Bureau of Citizenship & Immigration Services (BCIS), Commerce, Dept of (DOC), Commodity Futures Trading Commission (CFTC), Consumer Product Safety Commission (CPSC), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Intl Trade Administration (ITA), Justice, Dept of (DOJ), Labor, Dept of (DOL), Natl Security Council (NSC), Office of Science & Technology Policy (OSTP), Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), State, Dept of (DOS), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Agency for International Development (USAID), U.S. Customs & Border Protection, U.S. Immigration & Customs Enforcement (ICE), U.S. International Trade Commission (ITC), U.S. Trade Representative (USTR)

Issues relating to FDA regulation of cosmetics, including Good Manufacturing Practices, modernization, import safety, fragrance ingredients, national uniformity and FDA resources; International trade and harmonization; H.R.1385, Safe Cosmetics and Personal Care Products Act of 2013; H.R. 4250 / S. 2141, Sunscreen Innovation Act

Client expense: $200,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Pseudoephedrine Potential legislation to implement real-time, stop-sale electronic tracking system for sales of medications containing pseudoephedrine in order to preserve consumer access to the ingredient, common in popular cold and allergy medications (no bill number) and oppose prescription requirement (no bill number). H.R. 4502 - Stop Meth Labs and Enhance Patient Access Act of 2014 (all sections). Would grant additional authority to the Drug Enforcement Administration (DEA) to grant exemptions to the provisions of the Combat Methamphetamine Epidemic Act of 2005 (P.L. 109-177). Over-the-counter (OTC) medicines; Manufacturing and importation of OTC drugs; Mandatory recall authority of the FDA; Rx-to-OTC Switch Supporting a process within FDA that ensures clarity and timely outcomes for the FDA, applicants and stakeholders, as well as utilizing existing technologies to further streamline the prescription-to-nonprescription switch application process without changing the existing clear distinction between prescription and nonprescription medicines. H.R. 4250/S. 2141 - Sunscreen Innovation Act. Would require FDA to approve or deny new sunscreen ingredient applications under the "time and extent" application (TEA) process within a certain timeframe after submission; all sections.

Client expense: $230,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Over-the-counter (OTC) medicines; Manufacturing and importation of OTC drugs; Mandatory recall authority of the FDA; Rx-to-OTC SwitchSupporting a process within FDA that ensures clarity and timely outcomes for the FDA, applicants and stakeholders, as well as utilizing existing technologies to further streamline the prescription-to-nonprescription switch application process without changing the existing clear distinction between prescription and nonprescription medicines. H.R. 4250/S. 2141 - Sunscreen Innovation Act. Would require FDA to approve or deny new sunscreen ingredient applications under the "time and extent" application (TEA) process within a certain timeframe after submission; all sections.

Client expense: $230,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Sunscreen Innovation ACt, H.R. 4250, S. 2141. Support for the Sunscreen Innovation Act, intended to require FDA to review and act on Time and Extent Applications for sunscreen active ingredients that have been marketed elsewhere but not yet approved in the United States

Client expense: $540,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)

H.R.4250/S.2141, Sunscreen Innovation Act. Legislation and regulations affecting medical devices, pharmaceuticals, cosmetics and other consumer products. H.R.83, Consolidated and Further Continuing Appropriations Act, 2015; issues related to Ebola funding.

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 1385, Safe Cosmetics and Personal Care Products Act. FDA modernization of cosmetics. HR 4250, S2141- Sunscreen Innovation Act.

Client expense: Not reported · Firm income: $30,000

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

Over the counter drug approval process for sunscreen ingredients; H.R. 4250 and S.2141, the Sunscreen Innovation Act; H.R. 4800, FY 2015 Agriculture-FDA Appropriations Act.

Client expense: Not reported · Firm income: $110,000

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, White House Office

Over the counter drug approval process for sunscreen ingredients; H.R. 4250 and S.2141, the Sunscreen Innovation Act; H.R. 4800, FY 2015 Agriculture-FDA Appropriations Act.

Client expense: Not reported · Firm income: $110,000

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, White House Office

HR 1309 - Health Information Technology Action of 2013 - Excludes pathologists from receiving incentives for purchasing electronic health records as well as being exempt from payment penalties under meaningful use standards. HR 1180, S 577, HR 2914 - GME legislation - proposed legislation to increase the number of federally funded residency slots HR 2914 - Stark Self-Referral Law HR 4250, S 2141 - Sunscreen Innovation Act.

Client expense: $292,496 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues relating to health disparities, health care reform, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including H.R.1666 & S.2800, the Patient Centered Quality Care for Life Act, and, H.R.1339 & S.641, the Palliative Care and Hospice Education and Training Act; S.621 and H.R.2607 & S.1251, the Caroline Pryce Walker Conquer Childhood Cancer Act; H.R.2058 & S.1247 the Childhood CancerSurvivors Quality of Life Act; H.R.2019, the Kids First Research Act; and H.R.460, the Patients' Access to Treatments Act; H.R.5145 & S.2622, the Breast Density & Mammography Reporting Act, H.R.4250 and S.2141, the Sunscreen Innovation Act, and regulations relating to tanning beds. In addition, regulatory issues before the F.D.A relating to laboratory developed tests, colorectal cancer screening tests, electronic medical devices, and issues relating to the 21st Century Cures Initiative of the House Energy & Commerce Committee.

Client expense: $1,210,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office

Advocate for improved access to specialty drugs for patients with chronic conditions (H.R. 460, Patients' Access to Treatments Act of 2013). Advocate for truth in advertising for health care providers (H.R. 1427, Truth in Healthcare Marketing Act of 2013). Lobby Members of Congress to join the Congressional Skin Cancer Caucus. Lobby Congress to protect and preserve the in-office use of compounded pharmaceuticals without a patient prescription (H.R. 3204, Drug Quality and Security Act/Public Law No: 113-54). Lobby Congress on legislation to remove non-discrimination requirements relating to health care providers. (H.R. 2817, Protect Patient Access to Quality Health Professionals Act of 2013). Advocate for legislation that would allow for Flexible Spending Accounts (FSAs) to be used to cover over-the-counter (OTC) drugs (S. 1647, H.R. 2835, Restoring Access to Medication Act). Lobby Congress on legislation to create a transparent and predictable review process for sunscreen ingredients (S. 2141/H.R. 4250 Sunscreen Innovation Act). Lobby Congress on issues related to telemedicine. Advocate for adequate and accurate network coverage for dermatologic care within health insurance exchange networks. Advocate on on use and availability of health care data.

Client expense: $410,421 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Dextromethorphan Abuse Reduction; Regulation of OTC drugs, devices and cosmetics; S.644, Preventing Abuse of Cough Treatments Act of 2013; HR 3969, Preventing Abuse of Cough Treatments Act of 2013; S.2141, The Sunscreen Innovation Act; HR 4250, The Sunscreen Innovation Act; HR 4895/S.2902, Microbead-Free Waters Act of 2014; HR 5613, Protecting Our Kids' Medicine Act of 2014

Client expense: $1,060,676 · Firm income: Not reported

Government targets: Bureau of Citizenship & Immigration Services (BCIS), Commerce, Dept of (DOC), Commodity Futures Trading Commission (CFTC), Consumer Product Safety Commission (CPSC), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), Federal Communications Commission (FCC), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Intl Trade Administration (ITA), Justice, Dept of (DOJ), Natl Security Council (NSC), Office of Science & Technology Policy (OSTP), Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), State, Dept of (DOS), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Agency for International Development (USAID), U.S. Customs & Border Protection, U.S. Immigration & Customs Enforcement (ICE), U.S. International Trade Commission (ITC), U.S. Trade Representative (USTR)

H.R. 1385, to amend title VI of the Federal Food, Drug, and Cosmetic Act to ensure the safe use of cosmetics, and for other purposes. H.R. 3990, to prevent and mitigate identity theft, to ensure privacy, to provide notice of security breaches and to enhance criminal penalties, law enforcement assistance and other protections against security breaches, fraudulent access and misuse of personally identifiable information. H.R. 4148, to phase out cosmetic animal testing and the sale of cosmetics tested on animals. H.R. 4215, to strengthen privacy and data security. H.R. 4250, to amend the Federal Food, Drug and Cosmetic Act to provide an alternative process for review of safety and effectiveness of nonprescription sunscreen active ingredients and for other purposes. H.R. 4381, to protect the privacy of individuals' personal genetic information and other personal identifier information. H.R. 4400, to protect consumers by requiring reasonable security policies and procedures to protect data containing personal information, and to provide for nationwide notice in the event of a security breach; to Energy & Commerce. HR 4759, the Designer Anabolic Steroid Control Act of 2014. HR 4883, the Microbead-Free Waters Act of 2014. HR 4974, the End Operation Choke Point Act of 2014. S. 1193, to require certain entities that collect and maintain personal information of individuals to secure such information and to provide notice to such individuals in the case of a breach of security involving such information, and for other purposes S. 1897, to prevent and mitigate identity theft, to ensure privacy, to provide notice of security breaches and to enhance criminal penalties, law enforcement assistance and other protections against security breaches, fraudulent access and misuse of personally identifiable information; to Judiciary. S. 1903, to provide greater fee disclosures for consumers who have prepaid cards, and for other purposes. S. 1927, to protect information relating to consumers, to require notice of security breaches, and for other purposes. S. 1976, to protect consumers by requiring reasonable security policies and procedures to protect data containing personal information and to provide for nationwide notice in the event of a breach of security. S. 1995, to protect consumers by mitigating the vulnerability of personally identifiable information to theft through a security breach, providing notice and remedies to consumers in the wake of such a breach, holding companies accountable for preventable breaches, facilitating the sharing of post-breach technical information between companies and enhancing criminal and civil penalties and other protections against the unauthorized collection or use of personally identifiable information. S. 2012, to amend the Controlled Substances Act to more effectively regulate anabolic steroids. S. 2141, to amend the Federal Food, Drug and Cosmetic Act to provide an alternative process for review of safety and effectiveness of nonprescription sunscreen active ingredients and for other purposes. S. 2572, the Ban Poisonous Additives Act of 2014. S. 2902 . Microbead-Free Waters Act of 2014

Client expense: $110,000 · Firm income: Not reported

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

Blackburn Amendment to H.R. 5016, Amendment to Stop Proposed Rule on Voluntary Recalls Chronic Hazard Advisory Panel (CHAP) Report on Phthalates CPSC "Certificates of Compliance" rulemaking ("Part 1110" rule) CPSC Commissioner nominations/confirmationsCPSC Proposed Interpretive Rule: Voluntary Remedial Actions and Guidelines for Voluntary Recall Notices CPSC Revisions to the Monthly Progress Reporting Form H.R. 4250, S. 2141, Sunscreen Innovation Act Third-Party Testing Burden Reduction

Client expense: $4,290,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Commodity Futures Trading Commission (CFTC), Consumer Product Safety Commission (CPSC), Council on Environmental Quality (CEQ), Defense, Dept of (DOD), Energy, Dept of, Environmental Protection Agency (EPA), Export-Import Bank of the United States (EXIM Bank), Federal Communications Commission (FCC), Federal Motor Carrier Safety Administration, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Labor, Dept of (DOL), Pension Benefit Guaranty Corporation (PBGC), Pipeline & Hazardous Materials Safety Administration, SENATE, Securities & Exchange Commission (SEC), Small Business Administration (SBA), State, Dept of (DOS), Treasury, Dept of, U.S. Agency for International Development (USAID), U.S. Customs & Border Protection, U.S. International Trade Commission (ITC), U.S. Trade Representative (USTR), White House Office

S. ___ - Legislation that would improve oversight over cosmetic safety (e.g., labeling and safety substantiation); H.R.1385 - Safe Cosmetics and Personal Care Products Act of 2013, all sections; S.2141 and H.R.4250 - Sunscreen Innovation Act, all sections; S.2811 - Children and Firefighters Protection Act of 2014, all sections; H.R.4978 - Bottled Water Quality Information Act, all sections; and S. ___ - Legislation that would require disclosure of information related to bottled water.

Client expense: $113,388 · Firm income: Not reported

Government targets: Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

S. ___ - Legislation that would improve oversight over cosmetic safety (e.g., labeling and safety substantiation); H.R.1385 - Safe Cosmetics and Personal Care Products Act of 2013, all sections; S.2141 and H.R.4250 - Sunscreen Innovation Act, all sections; S.2811 - Children and Firefighters Protection Act of 2014, all sections; H.R.4978 - Bottled Water Quality Information Act, all sections; and S. ___ - Legislation that would require disclosure of information related to bottled water.

Client expense: $7,829 · Firm income: Not reported

Government targets: Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

H.R.4250/S.2141, Sunscreen Innovation Act. Legislation and regulations affecting medical devices, pharmaceuticals, cosmetics and other consumer products.

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues relating to FDA regulation of cosmetics, including Good Manufacturing Practices, modernization, import safety, fragrance ingredients, national uniformity and FDA resources; International trade and harmonization; H.R.1385, Safe Cosmetics and Personal Care Products Act of 2013; H.R. 4250 / S. 2141, Sunscreen Innovation Act

Client expense: $200,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Advocate for improved access to specialty drugs for patients with chronic conditions (H.R. 460, Patients' Access to Treatments Act of 2013). Advocate for truth in advertising for health care providers (H.R. 1427, Truth in Healthcare Marketing Act of 2013). Lobby Members of Congress to join the Congressional Skin Cancer Caucus.Lobby Congress to protect and preserve the in-office use of compounded pharmaceuticals without a patient prescription (H.R. 3204, Drug Quality and Security Act/Public Law No: 113-54). Lobby Congress on legislation to remove non-discrimination requirements relating to health care providers. (H.R. 2817, Protect Patient Access to Quality Health Professionals Act of 2013). Advocate for legislation that would allow for Flexible Spending Accounts (FSAs) to be used to cover over-the-counter (OTC) drugs (S. 1647, H.R. 2835, Restoring Access to Medication Act). Advocate for adequate and accurate network coverage for dermatologic care within Medicare Advantage and health insurance exchange networks (S. 2552/H.R. 4998, Medicare Advantage Participant Bill of Rights Act of 2014). Lobby Congress on legislation to create a transparent and predictable review process for sunscreen ingredients (S. 2141/H.R. 4250 Sunscreen Innovation Act). Lobby Congress on issues related to telemedicine (H.R. 5380, the Medicare Telehealth Parity Act). Advocate on on use and availability of health care data.

Client expense: $416,696 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Sunscreen Innovation Act, H.R. 4250, S. 2141. BASF supports updating the process for approval of new sunscreen active ingredients as part of the Over-the-Counter drug review process

Client expense: $800,000 · Firm income: Not reported

Government targets: Council on Environmental Quality (CEQ), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)

Over-the-counter (OTC) medicines; Manufacturing and importation of OTC drugs; Mandatory recall authority of the FDA; Rx-to-OTC SwitchSupporting a process within FDA that ensures clarity and timely outcomes for the FDA, applicants and stakeholders, as well as utilizing existing technologies to further streamline the prescription-to-nonprescription switch application process without changing the existing clear distinction between prescription and nonprescription medicines. H.R. 4250/S. 2141 - Sunscreen Innovation Act. Would require FDA to approve or deny new sunscreen ingredient applications under the "time and extent" application (TEA) process within a certain timeframe after submission; all sections.

Client expense: $220,000 · Firm income: Not reported

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

Tanning Bed Cancer Control Act, Issues pertaining to the regulation of tanning beds Sunlamp regulation issues H.R.4250/S.2141, Sunscreen Innovation Act, Sunscreen related issues

Client expense: Not reported · Firm income: $10,000

Government targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Interior, Dept of (DOI), Natl Institutes of Health (NIH), SENATE

HR 1385, Safe Cosmetics and Personal Care Products Act. FDA modernization of cosmetics. HR 4250, S2141- Sunscreen Innovation Act.

Client expense: Not reported · Firm income: $30,000

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

Over the counter drug approval process for sunscreen ingredients; H.R. 4250 and S.2141, the Sunscreen Innovation Act; H.R. 4800, FY 2015 Agriculture-FDA Appropriations Act.

Client expense: Not reported · Firm income: $150,000

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, White House Office

Over the counter drug approval process for sunscreen ingredients; H.R. 4250 and S.2141, the Sunscreen Innovation Act; FY 2015 Agriculture-FDA Appropriations Act.

Client expense: Not reported · Firm income: $150,000

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

H.R. 1385, to amend title VI of the Federal Food, Drug, and Cosmetic Act to ensure the safe use of cosmetics, and for other purposes.H.R. 3990, to prevent and mitigate identity theft, to ensure privacy, to provide notice of security breaches and to enhance criminal penalties, law enforcement assistance and other protections against security breaches, fraudulent access and misuse of personally identifiable information. H.R. 4148, to phase out cosmetic animal testing and the sale of cosmetics tested on animals. H.R. 4215, to strengthen privacy and data security. H.R. 4250, to amend the Federal Food, Drug and Cosmetic Act to provide an alternative process for review of safety and effectiveness of nonprescription sunscreen active ingredients and for other purposes. H.R. 4381, to protect the privacy of individuals' personal genetic information and other personal identifier information. H.R. 4400, to protect consumers by requiring reasonable security policies and procedures to protect data containing personal information, and to provide for nationwide notice in the event of a security breach; to Energy & Commerce. HR 4759, the Designer Anabolic Steroid Control Act of 2014. HR 4883, the Microbead-Free Waters Act of 2014. HR 4974, the End Operation Choke Point Act of 2014. S. 1193, to require certain entities that collect and maintain personal information of individuals to secure such information and to provide notice to such individuals in the case of a breach of security involving such information, and for other purposes S. 1897, to prevent and mitigate identity theft, to ensure privacy, to provide notice of security breaches and to enhance criminal penalties, law enforcement assistance and other protections against security breaches, fraudulent access and misuse of personally identifiable information; to Judiciary. S. 1903, to provide greater fee disclosures for consumers who have prepaid cards, and for other purposes. S. 1927, to protect information relating to consumers, to require notice of security breaches, and for other purposes. S. 1976, to protect consumers by requiring reasonable security policies and procedures to protect data containing personal information and to provide for nationwide notice in the event of a breach of security. S. 1995, to protect consumers by mitigating the vulnerability of personally identifiable information to theft through a security breach, providing notice and remedies to consumers in the wake of such a breach, holding companies accountable for preventable breaches, facilitating the sharing of post-breach technical information between companies and enhancing criminal and civil penalties and other protections against the unauthorized collection or use of personally identifiable information. S. 2012, to amend the Controlled Substances Act to more effectively regulate anabolic steroids. S. 2141, to amend the Federal Food, Drug and Cosmetic Act to provide an alternative process for review of safety and effectiveness of nonprescription sunscreen active ingredients and for other purposes. S. 2572, the Ban Poisonous Additives Act of 2014.

Client expense: $110,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of, U.S. Trade Representative (USTR)

Over the counter drug approval process for sunscreen ingredients; H.R. 4250 and S.2141, the Sunscreen Innovation Act; H.R. 4800, FY 2015 Agriculture-FDA Appropriations Act.

Client expense: Not reported · Firm income: $150,000

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, White House Office

Issues relating to health disparities, health care reform, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including the following legislation to be reintroduced from the 112th Congress: H.R.1851 and S.881, the Family Act; the as-yet not introduced Health Equity and Accountability Act; H.R.1666, the Patient Centered Quality Care For Life Act, and, H.R.1339 & S.641, the Palliative Care andHospice Education and Training Act; S.621 and H.R.2607 and S.1251, the Caroline Pryce Walker Conquer Childhood Cancer Act; H.R.2058 & S.1247 the Childhood Cancer Survivors Quality of Life Act; H.R.2019, the Kids First Research Act; and H.R.460, the Patients' Access to Treatments Act; H.R.3404, the Breast Density & Mammography Reporting Act, H.R.4250 and S.2141, legislation to create a new FDA approval pathway for O.T.C. sunscreen products.

Client expense: $610,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office

Issues relating to health disparities, health care reform, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including H.R.1666, the Patient Centered Quality Care For Life Act, and, H.R.1339 & S.641, the Palliative Care and Hospice Education and Training Act; S.621 and H.R.2607 and S.1251, the Caroline Pryce Walker Conquer Childhood Cancer Act; H.R.2058 & S.1247 the Childhood Cancer Survivors Qualityof Life Act;H.R.2019, the Kids First Research Act; and H.R.460, the Patients' Access to Treatments Act; H.R.5145 & S.2622, the Breast Density & Mammography Reporting Act, H.R.4250 and S.2141, the Sunscreen Innovation Act, and regulations relating to tanning beds.

Client expense: $980,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office

CPSC Proposed Interpretive Rule: Voluntary Remedial Actions and Guidelines for Voluntary Recall Notices CPSC Section 6(b) Policy Change H.R. 4250, S. 2141, Sunscreen Innovation Act Nomination of Bob Adler for CPSC CommissionerProposed CPSC Import Surveillance User Fee S. 1887, a bill on cooperation between the Consumer Product Safety Commission and foreign government agencies

Client expense: $2,520,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Commodity Futures Trading Commission (CFTC), Consumer Product Safety Commission (CPSC), Council of Economic Advisers (CEA), Council on Environmental Quality (CEQ), Energy, Dept of, Environmental Protection Agency (EPA), Export-Import Bank of the United States (EXIM Bank), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Intl Trade Administration (ITA), Natl Economic Council (NEC), Natl Institute of Standards & Technology (NIST), Natl Labor Relations Board (NLRB), Natl Security Council (NSC), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), Pension Benefit Guaranty Corporation (PBGC), SENATE, State, Dept of (DOS), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Agency for International Development (USAID), U.S. Customs & Border Protection, U.S. International Trade Commission (ITC), U.S. Trade Representative (USTR), White House Office

Dextromethorphan Abuse Reduction; Regulation of OTC drugs, devices and cosmetics; S.644, Preventing Abuse of Cough Treatments Act of 2013; HR 3969, Preventing Abuse of Cough Treatments Act of 2013; S.2141, The Sunscreen Innovation Act; HR 4250, The Sunscreen Innovation Act; HR 4895, Microbead-Free Waters Act of 2014

Client expense: $1,571,606 · Firm income: Not reported

Government targets: Bureau of Citizenship & Immigration Services (BCIS), Commerce, Dept of (DOC), Commodity Futures Trading Commission (CFTC), Consumer Product Safety Commission (CPSC), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), Federal Communications Commission (FCC), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Intl Trade Administration (ITA), Justice, Dept of (DOJ), Natl Security Council (NSC), Office of Science & Technology Policy (OSTP), Patent & Trademark Office (PTO), SENATE, Securities & Exchange Commission (SEC), State, Dept of (DOS), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Agency for International Development (USAID), U.S. Customs & Border Protection, U.S. Immigration & Customs Enforcement (ICE), U.S. International Trade Commission (ITC), U.S. Trade Representative (USTR)

Over-the-counter (OTC) medicines; Manufacturing and importation of OTC drugs; Mandatory recall authority of the FDA; Rx-to-OTC Switch; Sunscreen ingredientsSupporting a process within FDA that ensures clarity and timely outcomes for the FDA, applicants and stakeholders, as well as utilizing existing technologies to further streamline the prescription-to-nonprescription switch application process without changing the existing clear distinction between prescription and nonprescription medicines. H.R. 4250/S. 2141 - Sunscreen Innovation Act. Would require FDA to approve or deny new sunscreen ingredient applications under the "time and extent" application (TEA) process within a certain timeframe after submission; all sections.

Client expense: $230,000 · Firm income: Not reported

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

Issues relating to FDA regulation of cosmetics, including Good Manufacturing Practices, modernization, import safety, fragrance ingredients, national uniformity and FDA resources; International trade and harmonization; H.R.1385, Safe Cosmetics and Personal Care Products Act of 2013H.R. 4250 / S. 2141, Sunscreen Innovation Act

Client expense: $200,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)

Sunscreen Innovation Act, H.R. 4250, S. 2141. BASF supports improvements to the FDA provess of approving new sunscreen filters via the Time and Extent Application process

Client expense: $690,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Lobby in support of FDA examination of the current classification of indoor tanning beds. Advocate for improved access to specialty drugs for patients with chronic conditions (H.R. 460, Patients' Access to Treatments Act of 2013). Advocate for truth in advertising for health care providers (H.R. 1427, Truth in Healthcare Marketing Act of 2013).Lobby Congress to protect and preserve the in-office use of compounded pharmaceuticals without a patient prescription (H.R. 3204, Drug Quality and Security Act/Public Law No: 113-54). Lobby Congress on legislation to remove non-discrimination requirements relating to health care providers. (H.R. 2817, Protect Patient Access to Quality Health Professionals Act of 2013). Lobby Members of Congress to join the Congressional Skin Cancer Caucus. Advocate for legislation that would allow for Flexible Spending Accounts (FSAs) to be used to cover over-the-counter (OTC) drugs (S. 1647, H.R. 2835, Restoring Access to Medication Act). Advocate for adequate and accurate network coverage for dermatologic care within Medicare Advantage and health insurance exchange networks (S. 2552/H.R. 4998, Medicare Advantage Participant Bill of Rights Act of 2014). Lobby Congress on legislation to create a transparent and predictable review process for sunscreen ingredients (S. 2141/H.R. 4250 Sunscreen Innovation Act). Lobby Congress on issues related to telemedicine.

Client expense: $346,672 · Firm income: Not reported

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

S. ___ - Legislation that would improve oversight over cosmetic safety (e.g., labeling and safety substantiation); H.R.1385 - Safe Cosmetics and Personal Care Products Act of 2013, all sections; and S.2141 and H.R.4250 - Sunscreen Innovation Act, all sections.

Client expense: $130,093 · Firm income: Not reported

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

HR 1385, Safe Cosmetics and Personal Care Products Act. FDA modernization of cosmetics. HR 4250, S2141- Sunscreen Innovation Act.

Client expense: Not reported · Firm income: $30,000

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

Tanning Bed Cancer Control Act, Issues pertaining to the regulation of tanning beds Sunlamp regulation issues H.R.4250/S.2141, Sunscreen Innovation Act, Sunscreen related issues

Client expense: Not reported · Firm income: $20,000

Government targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Interior, Dept of (DOI), Natl Institutes of Health (NIH), SENATE

H.R. 1385, to amend title VI of the Federal Food, Drug, and Cosmetic Act to ensure the safe use of cosmetics, and for other purposes.H.R. 3990, to prevent and mitigate identity theft, to ensure privacy, to provide notice of security breaches and to enhance criminal penalties, law enforcement assistance and other protections against security breaches, fraudulent access and misuse of personally identifiable information. H.R. 4148, to phase out cosmetic animal testing and the sale of cosmetics tested on animals. H.R. 4215, to strengthen privacy and data security. H.R. 4250, to amend the Federal Food, Drug and Cosmetic Act to provide an alternative process for review of safety and effectiveness of nonprescription sunscreen active ingredients and for other purposes. H.R. 4381, to protect the privacy of individuals' personal genetic information and other personal identifier information. H.R. 4400, to protect consumers by requiring reasonable security policies and procedures to protect data containing personal information, and to provide for nationwide notice in the event of a security breach; to Energy & Commerce. S. 1193, to require certain entities that collect and maintain personal information of individuals to secure such information and to provide notice to such individuals in the case of a breach of security involving such information, and for other purposes S. 1897, to prevent and mitigate identity theft, to ensure privacy, to provide notice of security breaches and to enhance criminal penalties, law enforcement assistance and other protections against security breaches, fraudulent access and misuse of personally identifiable information; to Judiciary. S. 1903, to provide greater fee disclosures for consumers who have prepaid cards, and for other purposes. S. 1927, to protect information relating to consumers, to require notice of security breaches, and for other purposes. S. 1976, to protect consumers by requiring reasonable security policies and procedures to protect data containing personal information and to provide for nationwide notice in the event of a breach of security. S. 1995, to protect consumers by mitigating the vulnerability of personally identifiable information to theft through a security breach, providing notice and remedies to consumers in the wake of such a breach, holding companies accountable for preventable breaches, facilitating the sharing of post-breach technical information between companies and enhancing criminal and civil penalties and other protections against the unauthorized collection or use of personally identifiable information. S. 2012, to amend the Controlled Substances Act to more effectively regulate anabolic steroids. S. 2141, to amend the Federal Food, Drug and Cosmetic Act to provide an alternative process for review of safety and effectiveness of nonprescription sunscreen active ingredients and for other purposes.

Client expense: $110,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of, U.S. Trade Representative (USTR)

Issues relating to health disparities, health care reform, childhood cancer, quality of life and palliative care, federal health care programs, genetic information, cancer, nutrition, tanning beds, skin cancer, and wellness, including the following legislation to be reintroduced from the 112th Congress: H.R.1851 and S.881, the Family Act; the as-yet not introduced Health Equity and Accountability Act; H.R.1666, the Patient Centered Quality Care For Life Act, and, H.R.1339 & S.641, the Palliative Care andHospice Education and Training Act; S.621 and H.R.2607 and S.1251, the Caroline Pryce Walker Conquer Childhood Cancer Act; H.R.2058 & S.1247 the Childhood Cancer Survivors Quality of Life Act; H.R.2019, the Kids First Research Act; and H.R.460, the Patients' Access to Treatments Act; H.R.3404, the Breast Density & Mammography Reporting Act, H.R.4250 and S.2141, legislation to create a new FDA approval pathway for O.T.C. sunscreen products.

Client expense: $760,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade Representative (USTR), White House Office

Sunscreen Innovation Act, H.R. 4250 and S. 2141, legislation to reform the process of approving new sunscreen active ingredients via the Time and Extent Application (TEA) process as part of the Over-the-Counter (OTC) drug approval process

Client expense: $685,000 · Firm income: Not reported

Government targets: Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE